Table 3.
Biomarker Levels (mean pg/ml ± 95% CI) | Mann-Whitney Significance | |||||
---|---|---|---|---|---|---|
Benign | CEM Carcinoma | Serous Carcinoma | Benign vs. CEM | Benign vs. Serous | CEM vs. Serous | |
CA 1251 | 14.15±4.61 | 49.65±15.04 | 123.9±51.17 | *** | ** | *** |
CA 72-41 | 2.04±.285 | 13.5±7.9 | 4.39±2.06 | *** | ** | |
CD40L | 19457±4732 | 23522±4994 | 16414±5929 | * | ||
Cyfra 21-1 | 891±222 | 2323±718 | 2633±886 | *** | *** | |
EGFR | 8548±344 | 7233±397 | 7552±636 | *** | ** | |
FSH2 | 37487±5344 | 24744±5182 | 36471±7751 | ** | ||
HE4 | 5476±4357 | 74816±42866 | 43857±18512 | *** | *** | |
IGFBP-1 | 10178±1891 | 15509±3660 | 9734±3536 | * | ||
IL-10 | 15.67±2.63 | 32.48±10.78 | 20.79±4.31 | *** | ** | |
IL-2R | 355.7±57.2 | 541.6±105.2 | 651.6±169.8 | *** | *** | |
IL-6 | 19.67±3.4 | 31.55±5.87 | 27.07±9.01 | *** | ||
IL-7 | 8.5±.864 | 11.6±1.85 | 10.2±1.69 | *** | * | |
IL-8 | 15±3.91 | 24.8±15.17 | 16.9±5.24 | ** | * | |
IP-10 | 49.86±5.35 | 42.4±5.71 | 72.53±15.54 | * | *** | *** |
LH2 | 19118±2435 | 15767±2982 | 22441±4496 | ** | ** | |
MMP-2 | 150963±8262 | 131903±9126 | 137652±14133 | ** | ||
MMP-9 | 212302±34252 | 361810±62411 | 250084±64652 | *** | ** | |
MPO | 91818±21710 | 123134±30713 | 80550±30403 | * | ** | |
SMRP3 | 44227±19250 | 43804±15896 | 117660±49778 | *** | *** | |
sVCAM-1 | 876645±68143 | 772258±66047 | 796917±70051 | ** | ||
TgII4 | 9.44±1.38 | 14.34±1.61 | 14.95±3.09 | *** | *** | |
TNF-R2 | 1515±137 | 1798±186 | 1836±228 | * | ** | |
tPAI-1 | 35876±3432 | 47987±4514 | 36723±4949 | *** | ** |
U/ml,
IU/ml,
pM,
mU/ml CEM: clear cell, endometrioid, mucinous carcinoma
-p<0.05,
-p<0.01,
-p<0.001